Live Dana-Farber Cancer Institute News with Latest Updates

Live Dana-Farber Cancer Institute news and developments with the latest updates. Check out current Dana-Farber Cancer Institute news stories and find out what happened, what is going on with Dana-Farber Cancer Institute. Recent news updates about Dana-Farber Cancer Institute
Study finds signs of worsening pain management for patients with terminal cancer
From genes to memes: Algorithm may help scientists demystify complex networks
Healthy Neighborhoods Fund Gets Major Boost
Massachusetts Life Sciences Center funding to support a Metabolomics Facility at Dana-Farber
Biomaterial vaccines ward off broad range of bacterial infections and septic shock
Cancer screenings rebounded in late 2020 after COVID-related decline, but racial and economic disparities remain for some tests
Count Me In Launches Metastatic Breast Cancer Project in Spanish/Count Me
New research uncovers how cancers with common gene mutation develop resistance to targeted drugs
Antibiotic Novobiocin found to kill tumor cells with DNA-repair glitch
Dana-Farber/Boston Children’s again named a top pediatric cancer program
Study finds lower mortality rate for men at high risk for death from prostate cancer who received early postoperative radiation
Caroline Powers named Senior Vice President for External Affairs
Immunotherapy drug delays recurrence in kidney cancer patients
Hollings scientist receives Melanoma Research Alliance grant
Dana-Farber scientists team with British researchers to accelerate development of blood test for ovarian cancer
Survival benefits of immunotherapy combination persist for more than six years in patients with advanced melanoma
Statement regarding U.S. Supreme Court action on patent lawsuit
A. Thomas Look, MD, awarded 2021 Society of Memorial Sloan Kettering Prize Recipient for Contributions
Dana-Farber announces expanded joint research agreement with Novartis
Dana-Farber researchers present key studies at ASCO annual meeting 20 May
Immunotherapy combination shows benefit for patients with advanced melanoma, phase 3 trial shows
“45 is new 50” as age for colorectal cancer screening is lowered
Dana-Farber Cancer Institute announces $2 billion fundraising campaign to Defy Cancer
Delphi Research Group, Collaborators Honored for COVIDcast
Hale Family to Accelerate Pancreatic Cancer Research and Care with One of Largest Single Gifts Ever to Dana-Farber Cancer Institute
Dana-Farber announces $4 million funding opportunity to improve community health by increasing access to services
Esophageal Cancers Resurrect Ancient Retroviruses Hidden in Our Genome
Christopher Lathan appointed Chief Clinical Access and Equity Officer at Dana-Farber
Christopher Lathan appointed Chief Clinical Access and Equity Officer at Dana- Farber
Heidi E. Conway joins Dana-Farber to lead Human Resources Department
Dana-Farber and Harvard Street Neighborhood Health Center to connect patients to cancer services
For young patients with breast cancer, fertility concerns influence endocrine therapy decisions, study finds
Ludwig Princeton’s Eileen White and Ludwig Harvard’s Alan D’Andrea elected to National Academy of Sciences
Using CRISPR as a research tool to develop cancer treatments
Dana-Farber Cancer Institute faculty recognized as 2021 ASCO leaders in cancer care
Dana-Farber joins Multi-Cancer Early Detection Consortium to chart path forward for use of new technologies to improve early cancer
Dana-Farber nurses present research at 2021 Oncology Nursing Society Congress
Dana-Farber Cancer Institute receives 2021 Community Hero Award presented by Make-A-Wish Massachusetts and Rhode Island
Level of chromosomal abnormality in non-small cell lung cancer may predict response to immunotherapy
Dana-Farber to present more than 30 research studies at American Association for Cancer Research Annual Meeting 2021
Excellent outcomes reported for first targeted frontline therapy for high-risk pediatric Hodgkin lymphoma
Gift supports research into rare cancers, community-building
Breast Cancer Survivors’ Fear of Cancer Returning Linked to Genomic Test Results, Psychological Factors
Low-calorie diet and mild exercise improve survival for young people with leukemia
George Demetri, MD elected as a Fellow of American Association for Cancer Research Academy
Expert panel issues recommendations for addressing cancer inequities
First FDA approval of CAR T-cell therapy for multiple myeloma marks milestone for patients
New sequencing approach finds triple-negative breast cancers continue accumulating genetic changes during tumor growth